Skip to main content

Allarity Therapeutics, Inc. (ALLR)

Allarity Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: $7.45 - $10.25
Current IPO price range
Chart not available yet
Market Cap2.11B
Revenue (ttm)n/a
Net Income (ttm)-9.79M
Shares Out238.83M
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About ALLR

Allarity Therapeutics is a clinical stage biopharmaceutical company targeting some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates together with our proprietary DRP® companion diagnostics in a precision medicine approach. We pursue oncology therapeutic candidates that have been “de-risked” through substantiated prior clinical trials by other pharmaceutical companies, demonstrating that these candidates are well tolerated in the tested patient population and have shown promising signs of...

IndustryPharmaceutical Preparations
IPO DatePending
CEOSteve R. Carchedi
Employees13
Stock ExchangeNASDAQ
Ticker SymbolALLR
Full Company Profile

Financial Performance

Financial Statements

News

Allarity Therapeutics IPO Registration Document (S-1)

Allarity Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

5 days ago - SEC